N-(4-cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy]acetamide, 10mg

3-((Tert-butoxycarbonyl)amino)-3-(thiophen-3-yl)propanoic acid, 95%, 5g

2-Benzylpyrazine, 95.0%, 100mg

Methyl 2-((tert-butoxycarbonyl)amino)-3-nitrobenzoate, 95.0%, 100g

tert-Butyl 3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-carboxylate, 97%, 100mg

2-Ethylhexyl Acetate>98.0%(GC)500mL

2,2,3,3,3-Pentafluoropropyltriflate, 95.0%, 25g

4-Trifluoromethyl-oxazol-2-ylamine, 95.0%, 5g

Methyl L-azetidine-2-carboxylate hydrochloride, 97.0%, 5g

L(+)-tartaric acid, min. 99.5%, pa, ACS, ISO, 25 kg, plastic packaging.

4-Iodotoluene, 99.0%, 5g

2-Bromo-5-cyanothiazole, 98.0%, 250mg

7-Bromo-4-methoxy-1H-pyrrolo[3,2-c]pyridine, 98%, 100mg